These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 23480532

  • 1. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY, Yap HN, Chaw CS.
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
    Sinha VR, Agrawal MK, Kumria R.
    Curr Drug Deliv; 2005 Jan; 2(1):1-8. PubMed ID: 16305403
    [Abstract] [Full Text] [Related]

  • 4. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 5. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A, Vetchý D, Janovská L, Krejcová K, Rabisková M.
    Drug Dev Ind Pharm; 2008 Mar; 34(3):289-96. PubMed ID: 18363144
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV, Gu L, Soh JL, Heng PW.
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM, Heng PW.
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1383-7. PubMed ID: 11724226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
    Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N, Kleinebudde P, Puttipipatkhachorn S.
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The evaluation of modified microcrystalline cellulose for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F, Knight PE, Newton JM.
    Int J Pharm; 2008 Feb 28; 350(1-2):145-54. PubMed ID: 17905548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.